These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 39035613)

  • 1. Bloodstream infections in the era of the COVID-19 pandemic: Changing epidemiology of antimicrobial resistance in the intensive care unit.
    Ntziora F; Giannitsioti E
    J Intensive Med; 2024 Jul; 4(3):269-280. PubMed ID: 39035613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study.
    Bartoszewicz M; Czaban SL; Bartoszewicz K; Kuźmiuk D; Ładny JR
    Ther Adv Infect Dis; 2023; 10():20499361231207178. PubMed ID: 37869469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Burden of Carbapenem-Resistant
    Montrucchio G; Corcione S; Lupia T; Shbaklo N; Olivieri C; Poggioli M; Pagni A; Colombo D; Roasio A; Bosso S; Racca F; Bonato V; Della Corte F; Guido S; Della Selva A; Ravera E; Barzaghi N; Cerrano M; Caironi P; Berta G; Casalini C; Scapino B; Grio M; Parlanti Garbero M; Buono G; Finessi F; Erbetta S; Sciacca PF; Fiore G; Cerutti A; Livigni S; Silengo D; Agostini F; Berardino M; Navarra M; Vendramin S; Castenetto E; Liccardi MM; Manno E; Brazzi L; De Rosa FG
    J Clin Med; 2022 Sep; 11(17):. PubMed ID: 36079137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of ICU-Onset Bloodstream Infection: Prevalence, Pathogens, and Risk Factors Among 150,948 ICU Patients at 85 U.S. Hospitals.
    Gouel-Cheron A; Swihart BJ; Warner S; Mathew L; Strich JR; Mancera A; Follmann D; Kadri SS
    Crit Care Med; 2022 Dec; 50(12):1725-1736. PubMed ID: 36190259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of COVID-19 pandemic on healthcare-associated infections, antibiotic resistance and consumption rates in intensive care units.
    Önal U; Tüzemen Ü; Kazak E; Gençol N; Souleiman E; İmer H; Heper Y; Yılmaz E; Özakın C; Ener B; Akalin H
    Infez Med; 2023; 31(2):195-203. PubMed ID: 37283640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and predictors of carbapenem-resistant
    Papadimitriou-Olivgeris M; Fligou F; Spiliopoulou A; Koutsileou K; Kolonitsiou F; Spyropoulou A; Zotou A; Marangos M; Anastassiou ED; Christofidou M; Spiliopoulou I
    J Med Microbiol; 2017 Aug; 66(8):1092-1101. PubMed ID: 28758623
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study.
    Palanisamy N; Vihari N; Meena DS; Kumar D; Midha N; Tak V; Sharma A; Bohra GK; Kothari N; Dutt N; Bhatia PK; Garg MK; Misra S
    BMC Infect Dis; 2021 Sep; 21(1):933. PubMed ID: 34496787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared.
    Cogliati Dezza F; Arcari G; Alessi F; Valeri S; Curtolo A; Sacco F; Ceccarelli G; Raponi G; Alessandri F; Mastroianni CM; Venditti M; Oliva A
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic.
    Torrecillas M; Gumucio VD; Padullés A; Tubau F; Marco D; Shaw E; Fernández-Huerta M; Maisterra K; Grau I; Petito MM; Berbel D; Puig-Asensio M; Pérez XL; Domínguez MÁ; Sabater J; Ardanuy C; Càmara J
    Infect Prev Pract; 2022 Dec; 4(4):100241. PubMed ID: 36061570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study.
    Damonti L; Kronenberg A; Marschall J; Jent P; Sommerstein R; De Kraker MEA; Harbarth S; Gasser M; Buetti N
    Crit Care; 2021 Nov; 25(1):403. PubMed ID: 34809698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, Risk Factors, and Prognosis of Bloodstream Infections in COVID-19 Patients in Intensive Care: A Single-Center Observational Study.
    Kurt AF; Mete B; Urkmez S; Demirkiran O; Dumanli GY; Bozbay S; Dilken O; Karaali R; Balkan II; Saltoğlu N; Dikmen Y; Tabak F; Aygun G
    J Intensive Care Med; 2022 Oct; 37(10):1353-1362. PubMed ID: 35607286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance study of bloodstream infections, antimicrobial use, and resistance patterns among intensive care unit patients: A retrospective cross-sectional study.
    Ababneh MA; Al Domi M; Rababa'h AM
    Int J Crit Illn Inj Sci; 2022; 12(2):82-90. PubMed ID: 35845122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation.
    Bauer KA; Puzniak LA; Yu KC; Finelli L; Moise P; Ai C; Watts JA; Gupta V
    BMC Infect Dis; 2022 Nov; 22(1):841. PubMed ID: 36368931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream Infection in the Intensive Care Unit: Evolving Epidemiology and Microbiology.
    Munro C; Zilberberg MD; Shorr AF
    Antibiotics (Basel); 2024 Jan; 13(2):. PubMed ID: 38391509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).
    Pfaller MA; Carvalhaes CG; Smith CJ; Diekema DJ; Castanheira M
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115016. PubMed ID: 32111415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, time course, and risk factors for hospital-acquired bloodstream infections in a cohort of 14,884 patients before and during the COVID-19 pandemic.
    Taddei E; Pafundi PC; Masciocchi C; Fiori B; Segala FV; Antenucci L; Guerriero S; Pastorino R; Scarsi N; Damiani A; Sanguinetti M; De Pascale G; Fantoni M; Murri R; De Angelis G
    Infect Dis (Lond); 2023 Nov; 55(11):776-785. PubMed ID: 37750316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare-Associated Bloodstream Infections Due to Multidrug-Resistant
    Dobrović K; Škrobo T; Selec K; Jelić M; Čivljak R; Peršec J; Sakan S; Bušić N; Mihelčić A; Hleb S; Andrašević AT
    Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis.
    Allel K; Stone J; Undurraga EA; Day L; Moore CE; Lin L; Furuya-Kanamori L; Yakob L
    PLoS Med; 2023 Jun; 20(6):e1004199. PubMed ID: 37347726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial use and mortality among intensive care unit patients with bloodstream infections: implications for stewardship programs.
    Ababneh MA; Al Domi M; Rababa'h AM
    Heliyon; 2022 Aug; 8(8):e10076. PubMed ID: 35982844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.